Revadix
PrivateLast Round
Seed
Apr 11, 2025
Company Overview
Revadix is a biotechnology company developing small molecule therapies targeting the EPAC-1 protein to treat atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revadix Comparables
Compare Revadix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acesion Pharma | 80% | |
| Thryv Therapeutics | 77% | |
| Sanofi | 69% |
Revadix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 11, 2025 |
Key People
Founding team and executive leadership
Revadix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NLC Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 11, 2025
Seed round led by NLC Health Ventures.
Revadix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Revadix's valuation, stock price, and market status.
Is Revadix a public or private company?
Revadix is a private company.
What is the current stock price of Revadix?
Revadix is a private company with no public stock price. Caplight tracks Revadix's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Revadix worth (valuation)?
Valuation information for Revadix is not publicly available.
Can I buy Revadix stock?
Revadix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Revadix's last funding round?
Revadix's most recent funding round was Seed on April 11, 2025.
Who are the main investors in Revadix?
Key investors in Revadix include NLC Health Ventures.
Will Revadix IPO soon?
No public IPO plans have been announced for Revadix.
How can I track Revadix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Revadix's secondary market activity and sign up for updates.